Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Spotlight Innovation Inc (STLT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Spotlight Innovation Forms Corporate Partnership with University of Iowa Athletics to Promote New Chronic Pain Relief Product "Venodol"

URBANDALE, IA--(Marketwired - Sep 27, 2017) - Spotlight Innovation Inc. (OTCQB: STLT) today announced that it has formed a corporate partnership with University of Iowa Athletics that will provide ongoing...

STLT : 0.2390 (unch)
Spotlight Innovation Forms Corporate Partnership with University of Iowa Athletics to Promote New Chronic Pain Relief Product "Venodol"

URBANDALE, IA--(Marketwired - Sep 27, 2017) - Spotlight Innovation Inc. (OTCQB: STLT) today announced that it has formed a corporate partnership with University of Iowa Athletics that will provide ongoing...

STLT : 0.2390 (unch)
Spotlight Innovation Enters into Sponsored Research Agreement with Indiana University to Develop New Therapies for Spinal Muscular Atrophy

URBANDALE, Iowa , Aug. 16, 2017 /PRNewswire/ --  Spotlight Innovation Inc. (OTCQB: STLT) today announced that the Company has entered into a Sponsored Research Agreement with Indiana University...

STLT : 0.2390 (unch)
New Chronic Pain Relief Product "Venodol" Now Available for Pre-order at Venodol.com

Spotlight Innovation Inc. (OTCQB: STLT), a pharmaceutical company targeting rare, emerging and neglected diseases, today announced that its subsidiary Caretta Therapeutics' new over-the-counter chronic...

STLT : 0.2390 (unch)
New Chronic Pain Relief Product "Venodol" Now Available for Pre-order at Venodol.com

URBANDALE, Iowa , Aug. 7, 2017 /PRNewswire/ --  Spotlight Innovation Inc. (OTCQB: STLT), a pharmaceutical company targeting rare, emerging and neglected diseases, today announced that its subsidiary...

STLT : 0.2390 (unch)
Spotlight Innovation Subsidiary Caretta Therapeutics Engages Public Relations Firm TransMedia Group

Spotlight Innovation Inc. (OTCQB: STLT) today announced that its subsidiary Caretta Therapeutics, LLC, has engaged TransMedia Group to provide public relations support for Venodol, a new over-the-counter,...

STLT : 0.2390 (unch)
Spotlight Innovation Enters into Sponsored Research Agreement to Develop New Therapies for Spinal Muscular Atrophy

URBANDALE, Iowa , June 30, 2017 /PRNewswire/ --  Spotlight Innovation Inc. (OTCQB: STLT) today announced that the Company has entered into a Sponsored Research Agreement with Brigham and Women's...

STLT : 0.2390 (unch)
Spotlight Innovation to Present Poster at the Cure SMA 2017 Annual SMA Conference

Spotlight Innovation Inc. (OTCQB: STLT) today announced that the Company will participate in a family-friendly research poster session at the Cure SMA 2017 Annual SMA Conference, which the Company is supporting...

STLT : 0.2390 (unch)
Spotlight Innovation to Present Poster at the Cure SMA 2017 Annual SMA Conference

URBANDALE, Iowa , June 22, 2017 /PRNewswire/ -- Spotlight Innovation Inc. (OTCQB: STLT) today announced that the Company will participate in a family-friendly research poster session at the Cure...

STLT : 0.2390 (unch)
Spotlight Innovation Inc. Issues Statement About Recent Stock Trading Activity

Spotlight Innovation Inc. (OTCQB: STLT) today announced that on June 15, 2017, it was made aware by OTC Markets of promotional activities surrounding the Company's common stock.

STLT : 0.2390 (unch)
Spotlight Innovation Inc. Issues Statement About Recent Stock Trading Activity

URBANDALE, Iowa , June 21, 2017 /PRNewswire/ --  Spotlight Innovation Inc. (OTCQB: STLT) today announced that on June 15, 2017 , it was made aware by OTC Markets of promotional activities...

STLT : 0.2390 (unch)
Spotlight Innovation Subsidiary Caretta Therapeutics Signs Second Venodol API Production Agreement

URBANDALE, Iowa , June 14, 2017 /PRNewswire/ -- Spotlight Innovation Inc. (OTCQB: STLT) today announced that its subsidiary Caretta Therapeutics, LLC, has signed a manufacturing agreement with...

STLT : 0.2390 (unch)
Spotlight Innovation Subsidiary Caretta Therapeutics Signs Second Venodol API Production Agreement

Spotlight Innovation Inc. (OTCQB: STLT) today announced that its subsidiary Caretta Therapeutics, LLC, has signed a manufacturing agreement with Orlando, FL-based contract manufacturing organization (CMO)...

STLT : 0.2390 (unch)
Spotlight Innovation Former CEO Returning Additional 1.6 Million Shares to Company Treasury

Spotlight Innovation Inc. (OTCQB: STLT) today announced that former Chief Executive Officer Cristopher Grunewald has agreed to return 1,618,627 shares of common stock to the Company treasury. The shares...

STLT : 0.2390 (unch)
Spotlight Innovation Subsidiary Caretta Therapeutics Begins the Manufacturing Process for Venodol, a New Over-the-Counter Product to Treat Chronic Pain

URBANDALE, Iowa , May 31, 2017 /PRNewswire/ --  Spotlight Innovation Inc. (OTCQB: STLT) today announced that subsidiary Caretta Therapeutics, LLC, has begun the process of manufacturing Venodol...

STLT : 0.2390 (unch)
Spotlight Innovation Appoints John Krohn Interim Chief Executive Officer

Spotlight Innovation Inc. (OTCQB: STLT) today announced that the Company's Board of Directors has accepted the resignation of Cristopher Grunewald as Chief Executive Officer (CEO) and appointed John M....

STLT : 0.2390 (unch)
Spotlight Innovation Commences Part 2 of Phase I Cancer Trial

URBANDALE, Iowa , March 10, 2017 /PRNewswire/ --  Spotlight Innovation Inc. (OTCQB: STLT) today announced that its subsidiary Celtic Biotech has begun Part 2 of its Phase I dose escalation...

IMCL : 0.1593 (+6.13%)
STLT : 0.2390 (unch)
OTCQX And OTCQB Companies To Present At 2017 ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

CATS : 3.53 (-2.49%)
OPRX : 1.4850 (-1.98%)
ICPW : 0.0775 (-51.56%)
CCNI : 0.4700 (unch)
RSSS : 1.2000 (unch)
FSSN : 0.1747 (+16.54%)
EXPI : 7.9500 (+1.92%)
MSRT : 0.3060 (+15.47%)
BRFH : 0.5869 (-0.51%)
CAPC : 0.5100 (+2.00%)
STLT : 0.2390 (unch)
MEEC : 0.2550 (-5.52%)
ESDI : 4.37 (+0.92%)
VLRX : 3.27 (-7.89%)
EXDI : 0.2000 (+33.33%)
RSASF : 0.5170 (+1.37%)
PURE : 1.0000 (+2.04%)
MKGI : 2.3200 (+0.13%)
NULF : 0.2400 (unch)
UNIR : 1.4500 (+8.21%)
ABWN : 1.1600 (+0.87%)
FTXP : 0.3700 (-7.50%)
ASPU : 8.66 (-3.78%)
PRHR : 1.3500 (+3.85%)
OTCM : 29.4000 (+0.77%)
ELIO : 2.3850 (-4.60%)
MATN : 0.1800 (-1.85%)
CKPT : 4.63 (-1.91%)
IWSY : 1.4400 (-2.70%)
AKTS : 6.55 (-3.68%)
CAFN : 4.40 (unch)
NMUS : 0.1430 (+2.14%)
STXS : 0.7950 (+1.92%)
ARTH : 0.7100 (-3.01%)
GDPP : 15.9500 (+4.59%)
MRNA : 1.8500 (-11.90%)
Spotlight Innovation to Present at 29th Annual ROTH Conference on March 15, 2017

URBANDALE, Iowa , March 7, 2017 /PRNewswire/ -- Spotlight Innovation Inc. (OTCQB: STLT), a pharmaceutical company targeting rare, emerging and neglected diseases, today announced that Company management...

STLT : 0.2390 (unch)

Van Meerten Stock Picks

5 Great Mid Caps
  Today you will find that I have varied a little bit from my usual search criteria.
KBH +0.30 , IPGP +2.52 , FSLR +1.07 , NVR -6.91 , TTWO +2.17
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 +0.22%) this morning are up +0.16% and European stocks are down -0.34% at a 1-week low. Investors continue to pour money into U.S. equity funds at the expense of European stock funds.... Read More

Chart of the Day

Chart of the Day

Maximus (MMS) is the Barchart CHartr of the Day.  The governmental consulting firm has a Trend Spotter buy signal, a Weighted Alpha of 32.85+ and gained 31.28% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed the Friday session with most contracts as much as a penny lower. A private export sale of 134,503 MT of corn was sold to Costa Rica as announced by the USDA through their daily export reporting system. The Friday Commitment of Tra...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.